Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 6 de 6
Filtre
Ajouter des filtres








Gamme d'année
1.
Chinese Journal of Applied Physiology ; (6): 94-97, 2006.
Article Dans Chinois | WPRIM | ID: wpr-254596

Résumé

<p><b>AIM</b>To investigate effect and mechanism of vasonatrin peptide (VNP) on Ca2+ activated K+ channels (K(Ca)) of vascular smooth muscle cells (VSMCs) isolated from rat mesentery arteries.</p><p><b>METHODS</b>Changes of K(Ca) induced by VNP were measured by the means of whole cell recording mode of patch clamp, furthermore effects of HS-142-1(0.3 g/L), 8-Br-cGMP and methylene blue (MB) were observed.</p><p><b>RESULTS</b>K(Ca) was significantly enhanced by VNP (10(-6) mol/L), which was mimicked by 8-Br-cGMP(10(-3) mol/L) and blocked completely by HS-142-1 or MB (2 x 10(-5) mol/L).</p><p><b>CONCLUSION</b>VNP increases K(Ca) of VSMCs isolated from rat mesenteric arteries, by binding with natriuretic peptide guanylate cyclase-coupled receptors and increasing the intracellular level of cGMP in VSMCs.</p>


Sujets)
Animaux , Mâle , Rats , Facteur atrial natriurétique , Pharmacologie , Artères mésentériques , Biologie cellulaire , Métabolisme , Muscles lisses vasculaires , Métabolisme , Physiologie , Canaux potassiques calcium-dépendants , Métabolisme , Rat Sprague-Dawley
2.
Acta Physiologica Sinica ; (6): 258-262, 2004.
Article Dans Anglais | WPRIM | ID: wpr-352783

Résumé

The immunological parameters were analyzed during pregnancy of Lewis rats by the methods of flow cytometry, thymidine incorporation and enzyme-linked immunospot (ELISPOT). MHC II of spleen mononuclear cells (MNCs) and CD11c of periphery blood MNCs was apparently downregulated in late pregnancy, while the costimulatory molecules B7-1 and B7-2 showed no difference. Increased expression of Th2 cytokines (IL-10, IL-4) and TGFbeta was detected in the spleen and peripheral blood MNCs in the third trimester by flow cytometry. No suppression of Th1 cytokine represented by IFNgamma was found. Furthermore, antigen specific proliferation of spleen and peripheral blood MNCs was unchanged, but higher proliferation of MNCs from mesenteric lymph nodes was shown in late pregnancy. There was an inhibition of antigen specific antibody production in pregnancy examined by ELISPOT. These data indicate the immunomodulatory effects of sex-hormones in pregnancy, which may be related to the remission of T cell-mediated autoimmune diseases during pregnancy.


Sujets)
Animaux , Femelle , Grossesse , Rats , Antigène CD80 , Allergie et immunologie , Antigènes CD11c , Allergie et immunologie , Interleukine-10 , Métabolisme , Interleukine-4 , Métabolisme , Agranulocytes , Allergie et immunologie , Complexe majeur d'histocompatibilité , Allergie et immunologie , Gestation animale , Allergie et immunologie , Rats de lignée LEW , Rate , Biologie cellulaire , Allergie et immunologie , Lymphocytes auxiliaires Th2 , Allergie et immunologie , Facteur de croissance transformant bêta , Métabolisme
3.
Acta Physiologica Sinica ; (6): 335-340, 2004.
Article Dans Chinois | WPRIM | ID: wpr-352772

Résumé

The purpose of this study was to investigate the effects of vasonatrin peptide (VNP) on electrically-induced intracellular calcium ([Ca(2+)](i)) transient and mechanism of the effects in the cardiac myocytes. The [Ca(2+)](i) transient was measured with a fluoremetric method. The effects of HS-142-1, 8-Br-cGMP and methylene blue (MB) on [Ca(2+)](i) transient in cardiac myocytes were also determined. Isoproterenol (Iso) at 10(-10)~10(-6) mol/L augmented electrically-induced [Ca(2+)](i) transient dose-dependently, which was (13+/-8)% (P>0.05), (26+/-13)% (P< 0.05), (66+/-10)% (P<0.01), (150+/-10)% (P<0.01) and (300+/-25)% (P<0.01), respectively. These effects were blocked by an beta-adrenergic bloker propranolol (10(-6) mol/L). The effect of Iso (10(-8) mol/L) on [Ca(2+)](i) transient was attenuated in a dose-dependent manner by VNP at 10(-10)~10(-6) mol/L, which was (99+/-3)% (P>0.05), (96+/-2)% (P<0.05), (84+/-6)% (P<0.01), (66+/-3)% (P<0.01) and (62+/-3)% (P<0.01), respectively. 8-Br-cGMP (10(-7)~10(-3) mol/L) aslo attenuated 10(-8) mol/L Iso-induced [Ca(2+)](i) transient dose-dependent. The effect of VNP on [Ca(2+)](i) transient was almost abolished in the presence of HS-142-1 (2x10(-5) mol/L), an antagonist of the natriuretic peptide guanylate cyclase (GC) receptors. MB (10(-5) mol/L), an inhibitor of GC, not only blocked the effect of VNP in myocytes, but also augmented electrically-induced [Ca(2+)](i) transient. VNP and HS-142-1 themselves did not change the [Ca(2+)](i) transient in the cardiac myocytes significantly. But MB augmented the [Ca(2+)](i) transient in the cardiac myocytes significantly. These results suggest that VNP attenuates [Ca(2+)](i) transient induced by Iso. This effect is possibly achieved by binding VNP with the natriuretic peptide GC receptors in the myocytes, leading to an increase in intracellular cGMP.


Sujets)
Animaux , Femelle , Mâle , Rats , Facteur atrial natriurétique , Pharmacologie , Calcium , Métabolisme , Canaux calciques , Métabolisme , GMP cyclique , Métabolisme , Dépression chimique , Guanylate cyclase , Métabolisme , Isoprénaline , Pharmacologie , Myocytes cardiaques , Métabolisme , Récepteur facteur natriurétique auriculaire , Métabolisme
4.
Acta Physiologica Sinica ; (6): 187-190, 2003.
Article Dans Chinois | WPRIM | ID: wpr-318919

Résumé

The purpose of this study was to investigate the vasorelaxing effect of vasonatrin peptide (VNP) on human intramammary artery (HIMA).The vasorelaxing effect of VNP on HIMA was measured by means of perfusion in vitro. The effects of HS-142-1, TEA, 8-Br-cGMP and methylene blue (MB) were also observed. It was found that VNP caused a concentration-dependent relaxation in HIMA which was independent of the endothelium. 8-Br-cGMP (0.1-1000 micromol/L) also caused a concentration-dependent relaxation in HIMA. The vasorelaxing effect of VNP disappeared in the presence of HS-142-1 (20 micromol/L), an antagonist of the natriuretic peptide guanylate cyclase (GC) receptor. MB (10 micromol/L), an inhibitor of GC, not only blocked completely the relaxation of HIMA, but also enhanced the vascular contraction induced by norepinephrine. TEA (1 mmol/L), an antagonist of calcium activated potassium channels (K(Ca)), reduced but not completely blocked the vasorelaxing effect of VNP. These findings suggest that VNP can relax HIMA, which is independent of the endothelium. This effect is possibly achieved by the binding of VNP with the natriuretic peptide GC receptors in the smooth muscle cells (SMCs), leading to an increase in intracellular cGMP level. Moreover, the vasorelaxing effect of VNP is associated with K(Ca).


Sujets)
Sujet âgé , Humains , Adulte d'âge moyen , Facteur atrial natriurétique , Pharmacologie , Relation dose-effet des médicaments , Techniques in vitro , Artères mammaires , Physiologie , Canaux potassiques calcium-dépendants , Métabolisme , Récepteurs à activité guanylate cyclase , Métabolisme , Vasodilatation , Physiologie
5.
Chinese Journal of Applied Physiology ; (6): 8-11, 2003.
Article Dans Chinois | WPRIM | ID: wpr-339693

Résumé

<p><b>AIM</b>To investigate how vasonatrin peptide (VNP) can attenuate the growth-promoting effect of hypoxia in cardiac fibroblasts cultured from neonatal rats.</p><p><b>METHODS</b>The cultured cardiac fibroblasts were divided randomly into four groups: control group, hypoxia group, hypoxia + VNP group and hypoxia + 8-Bromo-cGMP group. The growth of cardiac myocytes was measured by the means of MTT method. The effect of VNP on the intracellular level of cGMP and PCNA were measured by the means of radioimmunoassay and immunohistochemistry stain respectively.</p><p><b>RESULTS</b>Hypoxia (24 h) significantly increased the MTT A490nm value of cardiac fibroblasts (P < 0.05 vs control group). Both VNP (10(-7) mol/L) and 8-Bromo-cGMP (10(-3) mol/L) decreased MTT A490 nm value in cardiac fibroblast (P < 0.05 vs hypoxia group). VNP (10(-7) mol/L) increased the intracellular level of cGMP (P < 0.05 vs control and hypoxia group). Hypoxia (24 h) significantly increased the expression of proliferating cell nuclear antigen (PCNA) in cardiac myocytes (P < 0.05, vs control group), but VNP (10(-7) mol/L) decreased it.</p><p><b>CONCLUSION</b>VNP can attenuate hypoxia-induced growth-promoting effect in cardiac fibroblasts which is associated with the changes of cGMP and PCNA.</p>


Sujets)
Animaux , Rats , Animaux nouveau-nés , Facteur atrial natriurétique , Pharmacologie , Hypoxie cellulaire , Cellules cultivées , GMP cyclique , Métabolisme , Myoblastes cardiaques , Biologie cellulaire , Antigène nucléaire de prolifération cellulaire , Métabolisme , Rat Sprague-Dawley
6.
Acta Physiologica Sinica ; (6): 7-11, 2002.
Article Dans Chinois | WPRIM | ID: wpr-272993

Résumé

The present work was to investigate the effects of vasonatrin peptide (VNP) on cardiomyocyte protein synthesis induced by moderate hypoxia. In cultured neonatal rat cardiomyocytes, MTT methods, total protein measurement and (3)H-leucine incorporation were used to calculate the cell number and measure the protein synthesis of cardiomyocytes. Furthermore, radioimmunoassay was undertaken to observe the effects of VNP on the intracellular levels of cAMP, cGMP and the concentration of endothelin (ET) in the culture medium. The results showed that both the cell number and protein synthesis decreased with severe hypoxia for 24 h. In contrast, under moderate hypoxia, cardiomyocyte hypertrophy developed; the protein synthesis as evidenced by total protein content and 3H-eucine incorporation increased significantly. VNP reduced cardiomyocyte protein synthesis induced by moderate hypoxia in a dose-dependent manner. Furthermore, VNP increased the intracellular level of cGMP and decreased the concentration of ET in the culture medium under moderate hypoxia, but had no effect on the level of cAMP. These results suggest that VNP inhibits moderate hypoxia-induced protein synthesis in cultured neonatal rat cardiac myocytes. This effect is mediated, at least in part, by an increase in intracellular cGMP, a reduction in synthesis, and/or a release in ET of cardiomyocytes.


Sujets)
Animaux , Rats , Animaux nouveau-nés , Facteur atrial natriurétique , Pharmacologie , Hypoxie cellulaire , Cellules cultivées , AMP cyclique , Métabolisme , GMP cyclique , Métabolisme , Relation dose-effet des médicaments , Endothélines , Myocytes cardiaques , Métabolisme , Biosynthèse des protéines , Rat Sprague-Dawley
SÉLECTION CITATIONS
Détails de la recherche